Just a decade after Crispr was invented, the first drug to make use of the revolutionary gene-editing technology will be with regulators by the end of the year, with the promise that it will eventually transform the treatment of genetic diseases.
在Crispr发明仅十年后，第一种利用这一革命性的基因编辑技术的药物将在今年年底前与监管机构见面，并承诺它将最终改变遗传疾病的治疗。
您已阅读2%（313字），剩余98%（14202字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。